InsidersTradesSigma
Follow the 兰生股份 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). The latest transaction was reported on 7 September 2026 (Purchase). Among the most active insiders: 陈小宏. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
兰生股份 is a publicly traded company on the Shanghai Stock Exchange, specializing in the biotechnology sector. It focuses on the research and development of innovative pharmaceutical products.